335 related articles for article (PubMed ID: 24595267)
1. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
2. Investigating the extremes of the continuum of paracrine functions in CD34-/CD31+ CACs across diverse populations.
Landers-Ramos RQ; Sapp RM; VandeWater E; Macko J; Robinson S; Wang Y; Chin ER; Spangenburg EE; Prior SJ; Hagberg JM
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H162-H172. PubMed ID: 27793853
[TBL] [Abstract][Full Text] [Related]
3. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36.
Paramasivam S; Perumal SS; Ekambaram SP
Protein J; 2024 Apr; 43(2):243-258. PubMed ID: 38431537
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
5. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
Zhong X; Xie F; Chen L; Liu Z; Wang Q
Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
7. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
[TBL] [Abstract][Full Text] [Related]
8. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
[TBL] [Abstract][Full Text] [Related]
10. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
11. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
12. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
13. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
14. Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9.
Schenten V; Plançon S; Jung N; Hann J; Bueb JL; Bréchard S; Tschirhart EJ; Tolle F
Front Immunol; 2018; 9():447. PubMed ID: 29593718
[TBL] [Abstract][Full Text] [Related]
15. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
[TBL] [Abstract][Full Text] [Related]
16. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
[TBL] [Abstract][Full Text] [Related]
17. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
18. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
[TBL] [Abstract][Full Text] [Related]
19. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O
Front Immunol; 2023; 14():1110185. PubMed ID: 37056775
[TBL] [Abstract][Full Text] [Related]
20. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
